Signals, Powered By EquityPandit
The US health regulator has completed the inspection of Unichem’s Laboratories, Ghaziabad facility in Uttar Pradesh and the regulator has not issued any observation to it.
In a BSE filing it stated that, the company’s formulation manufacturing facility at Ghaziabad was inspected by the United States Food and Drug Administration (USFDA) from April 16, 2018 to April 20,2018. The inspection was completed with zero observations.
